|
Name |
(1R,2R,3E,7S,13S,15S)-2,15-dihydroxy-7-methyl-6-oxabicyclo[11.3.0]hexadeca-3,11-dien-5-one
|
| Molecular Formula | C16H24O4 | |
| IUPAC Name* |
(1R,2R,3E,7S,13S,15S)-2,15-dihydroxy-7-methyl-6-oxabicyclo[11.3.0]hexadeca-3,11-dien-5-one
|
|
| SMILES |
C[C@H]1CCCC=C[C@@H]2C[C@@H](C[C@H]2[C@@H](/C=C/C(=O)O1)O)O
|
|
| InChI |
InChI=1S/C16H24O4/c1-11-5-3-2-4-6-12-9-13(17)10-14(12)15(18)7-8-16(19)20-11/h4,6-8,11-15,17-18H,2-3,5,9-10H2,1H3/b6-4?,8-7+/t11-,12+,13-,14+,15+/m0/s1
|
|
| InChIKey |
KQNZDYYTLMIZCT-JBQJALHGSA-N
|
|
| Synonyms |
brefeldin A; 20350-15-6; BFA
|
|
| CAS | 20350-15-6 | |
| PubChem CID | 133640201 | |
| ChEMBL ID | NA |
Chemical Classification: |
|
|
|---|
| Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference | |
|---|---|---|---|---|---|---|---|---|
| Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference |
| Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name |
| Molecular Weight: | 280.36 | ALogp: | 2.0 |
| HBD: | 2 | HBA: | 4 |
| Rotatable Bonds: | 0 | Lipinski's rule of five: | Accepted |
| Polar Surface Area: | 66.8 | Aromatic Rings: | 2 |
| Heavy Atoms: | 20 | QED Weighted: | 0.529 |
| Caco-2 Permeability: | -4.555 | MDCK Permeability: | 0.00009350 |
| Pgp-inhibitor: | 0.139 | Pgp-substrate: | 0.206 |
| Human Intestinal Absorption (HIA): | 0.007 | 20% Bioavailability (F20%): | 0.008 |
| 30% Bioavailability (F30%): | 0.98 |
| Blood-Brain-Barrier Penetration (BBB): | 0.733 | Plasma Protein Binding (PPB): | 71.81% |
| Volume Distribution (VD): | 0.805 | Fu: | 28.96% |
| CYP1A2-inhibitor: | 0.04 | CYP1A2-substrate: | 0.116 |
| CYP2C19-inhibitor: | 0.027 | CYP2C19-substrate: | 0.27 |
| CYP2C9-inhibitor: | 0.03 | CYP2C9-substrate: | 0.434 |
| CYP2D6-inhibitor: | 0.008 | CYP2D6-substrate: | 0.157 |
| CYP3A4-inhibitor: | 0.513 | CYP3A4-substrate: | 0.211 |
| Clearance (CL): | 15.468 | Half-life (T1/2): | 0.862 |
| hERG Blockers: | 0.015 | Human Hepatotoxicity (H-HT): | 0.146 |
| Drug-inuced Liver Injury (DILI): | 0.104 | AMES Toxicity: | 0.049 |
| Rat Oral Acute Toxicity: | 0.066 | Maximum Recommended Daily Dose: | 0.944 |
| Skin Sensitization: | 0.892 | Carcinogencity: | 0.852 |
| Eye Corrosion: | 0.934 | Eye Irritation: | 0.523 |
| Respiratory Toxicity: | 0.391 |
| Similar NPs | Similar Drugs | ||||||
|---|---|---|---|---|---|---|---|
| NPs ID | NPs 2D Structure | Similarity Score | TTD ID | Drug 2D Structure | Similarity Score | ||
| ENC004795 | ![]() |
1.000 | D02FEM | ![]() |
0.248 | ||
| ENC003459 | ![]() |
1.000 | D0Z1FX | ![]() |
0.237 | ||
| ENC004394 | ![]() |
0.667 | D08PIQ | ![]() |
0.229 | ||
| ENC005240 | ![]() |
0.667 | D06WTZ | ![]() |
0.225 | ||
| ENC005841 | ![]() |
0.667 | D0H0ND | ![]() |
0.221 | ||
| ENC003969 | ![]() |
0.667 | D0WE3O | ![]() |
0.221 | ||
| ENC005842 | ![]() |
0.667 | D0CZ1Q | ![]() |
0.217 | ||
| ENC004316 | ![]() |
0.574 | D0V9DZ | ![]() |
0.217 | ||
| ENC005856 | ![]() |
0.500 | D0D2TN | ![]() |
0.217 | ||
| ENC004093 | ![]() |
0.492 | D03IKT | ![]() |
0.213 | ||